Cargando…

Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

Cisplatin (CDDP) resistance mechanisms were studied in a model of three germ cell tumour and three colon carcinoma cell lines representing intrinsically CDDP-sensitive and -resistant tumours respectively. The CDDP sensitivity of the cell lines mimicked the clinical situation. The glutathione levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sark, M. W., Timmer-Bosscha, H., Meijer, C., Uges, D. R., Sluiter, W. J., Peters, W. H., Mulder, N. H., de Vries, E. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033748/ https://www.ncbi.nlm.nih.gov/pubmed/7710929

Ejemplares similares

Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
por: Hettinga, J. V., et al.
Publicado: (1997)

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
por: Meijer, C., et al.
Publicado: (1990)

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours
por: Cierna, Zuzana, et al.
Publicado: (2020)

Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
por: Guchelaar, H. J., et al.
Publicado: (1992)

A new in vitro assay for quantitation of chemotherapy-induced mucositis.
por: Wymenga, A. N., et al.
Publicado: (1997)

Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
por: Bakardjieva-Mihaylova, Violeta, et al.
Publicado: (2019)

Human germ cell tumours: expression of γ-glutamyl transpeptidase and sensitivity to cisplatin
por: Hanigan, M H, et al.
Publicado: (1999)

Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
por: Timmer-Bosscha, H., et al.
Publicado: (1992)

Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells
por: Fung, M K L, et al.
Publicado: (2006)

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
por: Burger, H., et al.
Publicado: (1998)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
por: Groen, H. J., et al.
Publicado: (1995)

Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis
por: Schlippe, M von, et al.
Publicado: (2001)

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
por: Koster, R, et al.
Publicado: (2011)

Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)

Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours
por: Harpelunde Poulsen, K., et al.
Publicado: (2020)

GERM CELL TUMOURS
Publicado: (1984)

GERM CELL TUMOURS
Publicado: (1982)

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
por: Gerl, A., et al.
Publicado: (1996)

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
por: Nitzsche, B, et al.
Publicado: (2012)

Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.
por: Meijer, C., et al.
Publicado: (1997)

Germ cell tumour chemotherapy.
por: Horwich, A.
Publicado: (1989)

Somatic mutations of KIT in familial testicular germ cell tumours
por: Rapley, E A, et al.
Publicado: (2004)

IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance
por: Selfe, Joanna, et al.
Publicado: (2018)

Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
por: Schothorst, E M van, et al.
Publicado: (1999)

Clonal diversification and histogenesis of malignant germ cell tumours
por: Oliver, Thomas R. W., et al.
Publicado: (2022)

Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
por: Mendoza, J, et al.
Publicado: (2013)

Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)
por: Chan Wah Hak, Charleen, et al.
Publicado: (2019)

Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours
por: Funke, Kai, et al.
Publicado: (2023)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

Genomic copy number and expression patterns in testicular germ cell tumours
por: McIntyre, A, et al.
Publicado: (2007)

The role of surgery in metastatic testicular germ cell tumours (GCT).
por: Newlands, E. S., et al.
Publicado: (1989)

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours
por: Rijlaarsdam, M A, et al.
Publicado: (2011)

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours
por: Rijlaarsdam, M A, et al.
Publicado: (2012)

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid
por: Nienhuis, Hilde H., et al.
Publicado: (2015)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
por: Schaapveld, M, et al.
Publicado: (2012)

Clinical and genetic aspects of testicular germ cell tumours
por: Holzik, Martijn F Lutke, et al.
Publicado: (2008)

Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin
por: Kovacs, M S, et al.
Publicado: (1999)

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
por: Withoff, S., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_d7q317ob3ncv4l8coql3k0unia